Fairmount Funds Management LLC Diversified Active

CIK: 0001802528 · Show all filings

Period: Q3 2023 (← Previous) (Next →)

Filing Date: Nov 14, 2023

Total Value ($000): $831,173 (100.0% shares, 0.0% debt)

Holdings (20)

AXSM AXSOME THERAPEUTICS INC 19.7%
Value ($000) $163,629 Shares 2,341,238 Est. Cost $49.79 Unrealized +50.1%
NUVL NUVALENT INC 13.6%
Value ($000) $112,710 Shares 2,451,819 Est. Cost $22.67 Unrealized +95.8%
IMMUNOGEN INC 11.3%
Value ($000) $94,103 Shares 5,929,592 Est. Cost $18.87 Unrealized
APGE APOGEE THERAPEUTICS INC 7.5%
Value ($000) $62,647 Shares 2,941,176 Est. Cost $22.03 Unrealized 0.0%
MERUS N V 5.3%
Value ($000) $44,362 Shares 1,881,345 Est. Cost $24.17 Unrealized
KINIKSA PHARMACEUTICALS LTD 5.2%
Value ($000) $42,983 Shares 2,474,561 Est. Cost $16.43 Unrealized
ARGX ARGENX SE 5.0%
Value ($000) $41,173 Shares 83,747 Est. Cost $293.55 Unrealized
COGT COGENT BIOSCIENCES INC 4.2%
Value ($000) $34,700 Shares 3,558,975 Est. Cost $9.69 Unrealized +22.4%
SLNO SOLENO THERAPEUTICS INC 4.1%
Value ($000) $33,714 Shares 1,142,473 Est. Cost $6.05 Unrealized 0.0%
ELVN ENLIVEN THERAPEUTICS INC 3.5%
Value ($000) $29,115 Shares 2,131,369 Est. Cost $20.33 Unrealized -17.2%
IMVT IMMUNOVANT INC 3.5%
Value ($000) $28,793 Shares 750,000 Est. Cost $22.60 Unrealized 0.0%
RAYZEBIO INC 3.3%
Value ($000) $27,126 Shares 1,221,904 Est. Cost $22.20 Unrealized
DNTH DIANTHUS THERAPEUTICS INC 3.2%
Value ($000) $26,363 Shares 1,928,503 Est. Cost $12.62 Unrealized 0.0%
VRDN VIRIDIAN THERAPEUTICS INC 2.5%
Value ($000) $21,010 Shares 1,369,623 Est. Cost $15.80 Unrealized +20.8%
TYRA TYRA BIOSCIENCES INC 2.3%
Value ($000) $19,186 Shares 1,393,329 Est. Cost $14.88 Unrealized -0.4%
ASTRIA THERAPEUTICS INC 1.7%
Value ($000) $14,184 Shares 1,901,397 Est. Cost $11.99 Unrealized
TRVI TREVI THERAPEUTICS INC 1.4%
Value ($000) $11,256 Shares 5,163,287 Est. Cost $3.04 Unrealized -25.8%
TERN TERNS PHARMACEUTICALS INC 1.2%
Value ($000) $10,261 Shares 2,040,000 Est. Cost $3.72 Unrealized +70.8%
DBV TECHNOLOGIES SA 1.1%
Value ($000) $9,222 Shares 6,781,150 Est. Cost $2.30 Unrealized
SYRE AEGLEA BIOTHERAPEUTICS INC 0.6%
Value ($000) $4,636 Shares 378,421 Est. Cost $13.22 Unrealized 0.0%